Responses
Section 5: Patient safety and quality assurance
5PSQ-029 Case-report: cushing’s syndrome induced by inappropriate use of topical clobetasol: therapeutic drug monitoring can support clinical investigation
Compose a Response to This Article
Other responses
No responses have been published for this article.